 | • レポートコード：B-GIR08C2708 • 出版社/出版日：GlobalInfoResearch / 2019年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、115ページ • 納品方法：Eメール • 産業分類：Pharma & Healthcare |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、乳癌用HER-2標的薬の世界市場について調べ、まとめました。種類別セグメントは、トラスツズマブ、ペルツズマブ、ラパチニブ、ネラチニブ、トラスツズマブエムタンシン、ピロチニブ、その他等、用途別セグメントは、病院薬局、小売薬局、オンライン薬局等に区分しました。乳癌用HER-2標的薬の世界市場概観、企業動向、企業別乳癌用HER-2標的薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・乳癌用HER-2標的薬の市場概観 ・乳癌用HER-2標的薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・乳癌用HER-2標的薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・乳癌用HER-2標的薬の世界市場規模 ・乳癌用HER-2標的薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・乳癌用HER-2標的薬のアメリカ市場規模推移 ・乳癌用HER-2標的薬のカナダ市場規模推移 ・乳癌用HER-2標的薬のメキシコ市場規模推移 ・乳癌用HER-2標的薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・乳癌用HER-2標的薬のドイツ市場規模推移 ・乳癌用HER-2標的薬のイギリス市場規模推移 ・乳癌用HER-2標的薬のロシア市場規模推移 ・乳癌用HER-2標的薬のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・乳癌用HER-2標的薬の日本市場規模推移 ・乳癌用HER-2標的薬の中国市場規模推移 ・乳癌用HER-2標的薬の韓国市場規模推移 ・乳癌用HER-2標的薬のインド市場規模推移 ・乳癌用HER-2標的薬の東南アジア市場規模推移 ・乳癌用HER-2標的薬の南米市場分析（ブラジル、アルゼンチン等） ・乳癌用HER-2標的薬の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・乳癌用HER-2標的薬の種類別分析/販売量、売上、市場シェア（トラスツズマブ、ペルツズマブ、ラパチニブ、ネラチニブ、トラスツズマブエムタンシン、ピロチニブ、その他） ・乳癌用HER-2標的薬の用途別分析/市場規模（病院薬局、小売薬局、オンライン薬局） ・乳癌用HER-2標的薬の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・乳癌用HER-2標的薬の販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
The global HER-2 Targeted Drugs for Breast Cancer market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of HER-2 Targeted Drugs for Breast Cancer.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the HER-2 Targeted Drugs for Breast Cancer market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the HER-2 Targeted Drugs for Breast Cancer market by product type and applications/end industries.
Market Segment by Companies, this report covers
Roche
Chugai Pharmaceutical
GlaxoSmithKline
Novartis
Pfizer
CANbridge
Puma Biotechnology
Hengrui Medicine
Beacon Pharmaceuticals Limited
Hetero Drugs
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Trastuzumab
Pertuzumab
Lapatinib
Neratinib
Trastuzumab Emtansine
Pyrotinib
Other
Market Segment by Applications, can be divided into
Hospital
Clinic
Drug Center
Other
Table of Contents
1 HER-2 Targeted Drugs for Breast Cancer Market Overview
1.1 Product Overview and Scope of HER-2 Targeted Drugs for Breast Cancer
1.2 Classification of HER-2 Targeted Drugs for Breast Cancer by Types
1.2.1 Global HER-2 Targeted Drugs for Breast Cancer Revenue Comparison by Types (2019-2024)
1.2.2 Global HER-2 Targeted Drugs for Breast Cancer Revenue Market Share by Types in 2018
1.2.3 Trastuzumab
1.2.4 Pertuzumab
1.2.5 Lapatinib
1.2.6 Neratinib
1.2.7 Trastuzumab Emtansine
1.2.8 Pyrotinib
1.2.9 Other
1.3 Global HER-2 Targeted Drugs for Breast Cancer Market by Application
1.3.1 Global HER-2 Targeted Drugs for Breast Cancer Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Drug Center
1.3.5 Other
1.4 Global HER-2 Targeted Drugs for Breast Cancer Market by Regions
1.4.1 Global HER-2 Targeted Drugs for Breast Cancer Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) HER-2 Targeted Drugs for Breast Cancer Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) HER-2 Targeted Drugs for Breast Cancer Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) HER-2 Targeted Drugs for Breast Cancer Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) HER-2 Targeted Drugs for Breast Cancer Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) HER-2 Targeted Drugs for Breast Cancer Status and Prospect (2014-2024)
1.5 Global Market Size of HER-2 Targeted Drugs for Breast Cancer (2014-2024)
2 Manufacturers Profiles
2.1 Roche
2.1.1 Business Overview
2.1.2 HER-2 Targeted Drugs for Breast Cancer Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Roche HER-2 Targeted Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.2 Chugai Pharmaceutical
2.2.1 Business Overview
2.2.2 HER-2 Targeted Drugs for Breast Cancer Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Chugai Pharmaceutical HER-2 Targeted Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.3 GlaxoSmithKline
2.3.1 Business Overview
2.3.2 HER-2 Targeted Drugs for Breast Cancer Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 GlaxoSmithKline HER-2 Targeted Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.4 Novartis
2.4.1 Business Overview
2.4.2 HER-2 Targeted Drugs for Breast Cancer Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Novartis HER-2 Targeted Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.5 Pfizer
2.5.1 Business Overview
2.5.2 HER-2 Targeted Drugs for Breast Cancer Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Pfizer HER-2 Targeted Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.6 CANbridge
2.6.1 Business Overview
2.6.2 HER-2 Targeted Drugs for Breast Cancer Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 CANbridge HER-2 Targeted Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.7 Puma Biotechnology
2.7.1 Business Overview
2.7.2 HER-2 Targeted Drugs for Breast Cancer Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Puma Biotechnology HER-2 Targeted Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.8 Hengrui Medicine
2.8.1 Business Overview
2.8.2 HER-2 Targeted Drugs for Breast Cancer Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Hengrui Medicine HER-2 Targeted Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.9 Beacon Pharmaceuticals Limited
2.9.1 Business Overview
2.9.2 HER-2 Targeted Drugs for Breast Cancer Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Beacon Pharmaceuticals Limited HER-2 Targeted Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.10 Hetero Drugs
2.10.1 Business Overview
2.10.2 HER-2 Targeted Drugs for Breast Cancer Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Hetero Drugs HER-2 Targeted Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
3 Global HER-2 Targeted Drugs for Breast Cancer Market Competition, by Players
3.1 Global HER-2 Targeted Drugs for Breast Cancer Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 HER-2 Targeted Drugs for Breast Cancer Players Market Share
3.2.2 Top 10 HER-2 Targeted Drugs for Breast Cancer Players Market Share
3.3 Market Competition Trend
4 Global HER-2 Targeted Drugs for Breast Cancer Market Size by Regions
4.1 Global HER-2 Targeted Drugs for Breast Cancer Revenue and Market Share by Regions
4.2 North America HER-2 Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
4.3 Europe HER-2 Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific HER-2 Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
4.5 South America HER-2 Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa HER-2 Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
5 North America HER-2 Targeted Drugs for Breast Cancer Revenue by Countries
5.1 North America HER-2 Targeted Drugs for Breast Cancer Revenue by Countries (2014-2019)
5.2 USA HER-2 Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
5.3 Canada HER-2 Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
5.4 Mexico HER-2 Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
6 Europe HER-2 Targeted Drugs for Breast Cancer Revenue by Countries
6.1 Europe HER-2 Targeted Drugs for Breast Cancer Revenue by Countries (2014-2019)
6.2 Germany HER-2 Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
6.3 UK HER-2 Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
6.4 France HER-2 Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
6.5 Russia HER-2 Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
6.6 Italy HER-2 Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
7 Asia-Pacific HER-2 Targeted Drugs for Breast Cancer Revenue by Countries
7.1 Asia-Pacific HER-2 Targeted Drugs for Breast Cancer Revenue by Countries (2014-2019)
7.2 China HER-2 Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
7.3 Japan HER-2 Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
7.4 Korea HER-2 Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
7.5 India HER-2 Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia HER-2 Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
8 South America HER-2 Targeted Drugs for Breast Cancer Revenue by Countries
8.1 South America HER-2 Targeted Drugs for Breast Cancer Revenue by Countries (2014-2019)
8.2 Brazil HER-2 Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
8.3 Argentina HER-2 Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
8.4 Colombia HER-2 Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue HER-2 Targeted Drugs for Breast Cancer by Countries
9.1 Middle East and Africa HER-2 Targeted Drugs for Breast Cancer Revenue by Countries (2014-2019)
9.2 Saudi Arabia HER-2 Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
9.3 UAE HER-2 Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
9.4 Egypt HER-2 Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
9.5 Nigeria HER-2 Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
9.6 South Africa HER-2 Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
10 Global HER-2 Targeted Drugs for Breast Cancer Market Segment by Type
10.1 Global HER-2 Targeted Drugs for Breast Cancer Revenue and Market Share by Type (2014-2019)
10.2 Global HER-2 Targeted Drugs for Breast Cancer Market Forecast by Type (2019-2024)
10.3 Trastuzumab Revenue Growth Rate (2014-2024)
10.4 Pertuzumab Revenue Growth Rate (2014-2024)
10.5 Lapatinib Revenue Growth Rate (2014-2024)
10.6 Neratinib Revenue Growth Rate (2014-2024)
10.7 Trastuzumab Emtansine Revenue Growth Rate (2014-2024)
10.8 Pyrotinib Revenue Growth Rate (2014-2024)
10.9 Other Revenue Growth Rate (2014-2024)
11 Global HER-2 Targeted Drugs for Breast Cancer Market Segment by Application
11.1 Global HER-2 Targeted Drugs for Breast Cancer Revenue Market Share by Application (2014-2019)
11.2 HER-2 Targeted Drugs for Breast Cancer Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2014-2019)
11.4 Clinic Revenue Growth (2014-2019)
11.5 Drug Center Revenue Growth (2014-2019)
11.6 Other Revenue Growth (2014-2019)
12 Global HER-2 Targeted Drugs for Breast Cancer Market Size Forecast (2019-2024)
12.1 Global HER-2 Targeted Drugs for Breast Cancer Market Size Forecast (2019-2024)
12.2 Global HER-2 Targeted Drugs for Breast Cancer Market Forecast by Regions (2019-2024)
12.3 North America HER-2 Targeted Drugs for Breast Cancer Revenue Market Forecast (2019-2024)
12.4 Europe HER-2 Targeted Drugs for Breast Cancer Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific HER-2 Targeted Drugs for Breast Cancer Revenue Market Forecast (2019-2024)
12.6 South America HER-2 Targeted Drugs for Breast Cancer Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa HER-2 Targeted Drugs for Breast Cancer Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure HER-2 Targeted Drugs for Breast Cancer Picture
Table Product Specifications of HER-2 Targeted Drugs for Breast Cancer
Table Global HER-2 Targeted Drugs for Breast Cancer and Revenue (Million USD) Market Split by Product Type
Figure Global HER-2 Targeted Drugs for Breast Cancer Revenue Market Share by Types in 2018
Figure Trastuzumab Picture
Figure Pertuzumab Picture
Figure Lapatinib Picture
Figure Neratinib Picture
Figure Trastuzumab Emtansine Picture
Figure Pyrotinib Picture
Figure Other Picture
Table Global HER-2 Targeted Drugs for Breast Cancer Revenue (Million USD) by Application (2014-2024)
Figure HER-2 Targeted Drugs for Breast Cancer Revenue Market Share by Applications in 2018
Figure Hospital Picture
Figure Clinic Picture
Figure Drug Center Picture
Figure Other Picture
Table Global Market HER-2 Targeted Drugs for Breast Cancer Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America HER-2 Targeted Drugs for Breast Cancer Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe HER-2 Targeted Drugs for Breast Cancer Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific HER-2 Targeted Drugs for Breast Cancer Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America HER-2 Targeted Drugs for Breast Cancer Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa HER-2 Targeted Drugs for Breast Cancer Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global HER-2 Targeted Drugs for Breast Cancer Revenue (Million USD) and Growth Rate (2014-2024)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche HER-2 Targeted Drugs for Breast Cancer Type and Applications
Table Roche HER-2 Targeted Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Chugai Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Chugai Pharmaceutical HER-2 Targeted Drugs for Breast Cancer Type and Applications
Table Chugai Pharmaceutical HER-2 Targeted Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline HER-2 Targeted Drugs for Breast Cancer Type and Applications
Table GlaxoSmithKline HER-2 Targeted Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis HER-2 Targeted Drugs for Breast Cancer Type and Applications
Table Novartis HER-2 Targeted Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer HER-2 Targeted Drugs for Breast Cancer Type and Applications
Table Pfizer HER-2 Targeted Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table CANbridge Basic Information, Manufacturing Base and Competitors
Table CANbridge HER-2 Targeted Drugs for Breast Cancer Type and Applications
Table CANbridge HER-2 Targeted Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Puma Biotechnology Basic Information, Manufacturing Base and Competitors
Table Puma Biotechnology HER-2 Targeted Drugs for Breast Cancer Type and Applications
Table Puma Biotechnology HER-2 Targeted Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Hengrui Medicine Basic Information, Manufacturing Base and Competitors
Table Hengrui Medicine HER-2 Targeted Drugs for Breast Cancer Type and Applications
Table Hengrui Medicine HER-2 Targeted Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Beacon Pharmaceuticals Limited Basic Information, Manufacturing Base and Competitors
Table Beacon Pharmaceuticals Limited HER-2 Targeted Drugs for Breast Cancer Type and Applications
Table Beacon Pharmaceuticals Limited HER-2 Targeted Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Hetero Drugs Basic Information, Manufacturing Base and Competitors
Table Hetero Drugs HER-2 Targeted Drugs for Breast Cancer Type and Applications
Table Hetero Drugs HER-2 Targeted Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Global HER-2 Targeted Drugs for Breast Cancer Revenue (Million USD) by Players (2014-2019)
Table Global HER-2 Targeted Drugs for Breast Cancer Revenue Share by Players (2014-2019)
Figure Global HER-2 Targeted Drugs for Breast Cancer Revenue Share by Players in 2017
Figure Global HER-2 Targeted Drugs for Breast Cancer Revenue Share by Players in 2018
Figure Global Top 5 Players HER-2 Targeted Drugs for Breast Cancer Revenue Market Share in 2018
Figure Global Top 10 Players HER-2 Targeted Drugs for Breast Cancer Revenue Market Share in 2018
Figure Global HER-2 Targeted Drugs for Breast Cancer Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global HER-2 Targeted Drugs for Breast Cancer Revenue (Million USD) by Regions (2014-2019)
Table Global HER-2 Targeted Drugs for Breast Cancer Revenue Market Share by Regions (2014-2019)
Figure Global HER-2 Targeted Drugs for Breast Cancer Revenue Market Share by Regions (2014-2019)
Figure Global HER-2 Targeted Drugs for Breast Cancer Revenue Market Share by Regions in 2018
Figure North America HER-2 Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
Figure Europe HER-2 Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific HER-2 Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
Figure South America HER-2 Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa HER-2 Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
Table North America HER-2 Targeted Drugs for Breast Cancer Revenue by Countries (2014-2019)
Table North America HER-2 Targeted Drugs for Breast Cancer Revenue Market Share by Countries (2014-2019)
Figure North America HER-2 Targeted Drugs for Breast Cancer Revenue Market Share by Countries (2014-2019)
Figure North America HER-2 Targeted Drugs for Breast Cancer Revenue Market Share by Countries in 2018
Figure USA HER-2 Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
Figure Canada HER-2 Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
Figure Mexico HER-2 Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
Table Europe HER-2 Targeted Drugs for Breast Cancer Revenue (Million USD) by Countries (2014-2019)
Figure Europe HER-2 Targeted Drugs for Breast Cancer Revenue Market Share by Countries (2014-2019)
Figure Europe HER-2 Targeted Drugs for Breast Cancer Revenue Market Share by Countries in 2018
Figure Germany HER-2 Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
Figure UK HER-2 Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
Figure France HER-2 Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
Figure Russia HER-2 Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
Figure Italy HER-2 Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
Table Asia-Pacific HER-2 Targeted Drugs for Breast Cancer Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific HER-2 Targeted Drugs for Breast Cancer Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific HER-2 Targeted Drugs for Breast Cancer Revenue Market Share by Countries in 2018
Figure China HER-2 Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
Figure Japan HER-2 Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
Figure Korea HER-2 Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
Figure India HER-2 Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
Figure Southeast Asia HER-2 Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
Table South America HER-2 Targeted Drugs for Breast Cancer Revenue by Countries (2014-2019)
Table South America HER-2 Targeted Drugs for Breast Cancer Revenue Market Share by Countries (2014-2019)
Figure South America HER-2 Targeted Drugs for Breast Cancer Revenue Market Share by Countries (2014-2019)
Figure South America HER-2 Targeted Drugs for Breast Cancer Revenue Market Share by Countries in 2018
Figure Brazil HER-2 Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
Figure Argentina HER-2 Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
Figure Colombia HER-2 Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
Table Middle East and Africa HER-2 Targeted Drugs for Breast Cancer Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa HER-2 Targeted Drugs for Breast Cancer Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa HER-2 Targeted Drugs for Breast Cancer Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa HER-2 Targeted Drugs for Breast Cancer Revenue Market Share by Countries in 2018
Figure Saudi Arabia HER-2 Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
Figure UAE HER-2 Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
Figure Egypt HER-2 Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
Figure Nigeria HER-2 Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
Figure South Africa HER-2 Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
Table Global HER-2 Targeted Drugs for Breast Cancer Revenue (Million USD) by Type (2014-2019)
Table Global HER-2 Targeted Drugs for Breast Cancer Revenue Share by Type (2014-2019)
Figure Global HER-2 Targeted Drugs for Breast Cancer Revenue Share by Type (2014-2019)
Figure Global HER-2 Targeted Drugs for Breast Cancer Revenue Share by Type in 2018
Table Global HER-2 Targeted Drugs for Breast Cancer Revenue Forecast by Type (2019-2024)
Figure Global HER-2 Targeted Drugs for Breast Cancer Market Share Forecast by Type (2019-2024)
Figure Global Trastuzumab Revenue Growth Rate (2014-2019)
Figure Global Pertuzumab Revenue Growth Rate (2014-2019)
Figure Global Lapatinib Revenue Growth Rate (2014-2019)
Figure Global Neratinib Revenue Growth Rate (2014-2019)
Figure Global Trastuzumab Emtansine Revenue Growth Rate (2014-2019)
Figure Global Pyrotinib Revenue Growth Rate (2014-2019)
Figure Global Other Revenue Growth Rate (2014-2019)
Table Global HER-2 Targeted Drugs for Breast Cancer Revenue by Application (2014-2019)
Table Global HER-2 Targeted Drugs for Breast Cancer Revenue Share by Application (2014-2019)
Figure Global HER-2 Targeted Drugs for Breast Cancer Revenue Share by Application (2014-2019)
Figure Global HER-2 Targeted Drugs for Breast Cancer Revenue Share by Application in 2018
Table Global HER-2 Targeted Drugs for Breast Cancer Revenue Forecast by Application (2019-2024)
Figure Global HER-2 Targeted Drugs for Breast Cancer Market Share Forecast by Application (2019-2024)
Figure Global Hospital Revenue Growth Rate (2014-2019)
Figure Global Clinic Revenue Growth Rate (2014-2019)
Figure Global Drug Center Revenue Growth Rate (2014-2019)
Figure Global Other Revenue Growth Rate (2014-2019)
Figure Global HER-2 Targeted Drugs for Breast Cancer Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global HER-2 Targeted Drugs for Breast Cancer Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global HER-2 Targeted Drugs for Breast Cancer Revenue Market Share Forecast by Regions (2019-2024)
Figure North America HER-2 Targeted Drugs for Breast Cancer Revenue Market Forecast (2019-2024)
Figure Europe HER-2 Targeted Drugs for Breast Cancer Revenue Market Forecast (2019-2024)
Figure Asia-Pacific HER-2 Targeted Drugs for Breast Cancer Revenue Market Forecast (2019-2024)
Figure South America HER-2 Targeted Drugs for Breast Cancer Revenue Market Forecast (2019-2024)
Figure Middle East and Africa HER-2 Targeted Drugs for Breast Cancer Revenue Market Forecast (2019-2024)
乳癌VEGF標的薬の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global VEGF Targeted Drugs for Breast Cancer market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especial…- 乳癌用ER標的薬の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global ER Targeted Drugs for Breast Cancer market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially…
- 乳癌用標的薬の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global Targeted Drugs for Breast Cancer market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in…
- 乳癌用内分泌療法薬の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global Endocrine Therapy Drugs for Breast Cancer market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, espe…
- 小分子標的癌療法の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global Small Molecule Targeted Cancer Therapy market is valued at million USD in 2018 and is expected to reach million USD by the end of 2024, growing at a CAGR of between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in Chi…